Experiment 66772
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | KRUG,LM: MILLER,VA: KALEMKERIAN,GP: KRAUT,MJ: NG,KK: HEELAN,RT: PIZZO,BA: PEREZ,W: MC CLEAN,N: KRIS,MG:. (2000). PHASE II STUDY OF DOLASTATIN-10 IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER.. 11(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOLASTATIN-10 WAS TESTED IN 19 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). DOSE WAS GIVEN AT 400 MG/M2 IVP EVERY 3 WKS FOR 4 MONTHS. RESULTS FOUND NO OBJECTIVE RESPONSE IN PATIENTS. DOLASTATIN HAD AN ACCEPTABLE TOXICITY PROFILE. |
| Dose amount | 400.0 MCG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |